Comparison of Oral Lichen Planus and Systemic Lupus Erythematosus in Interleukins Level.

Lichen planus (LP) is a chronic inflammatory mucocutaneous disorder with unknown etiology. Systemic lupus erythematosus (SLE) is known as a prototypic autoimmune disease. Cytokines play a key role in the pathogenesis of both diseases. Various cytokines, such as interleukin 6 (IL-6), interleukin 10 (IL-10), interferon alpha (INF-a), and Tumor Necrosis Factor-alpha (TNF-a) can serve as biomarkers to predict SLE severity and monitor disease activity. In this review, we compare interleukins in oral lichen planus and lupus erythematosus as an autoimmune disease prototype. So, this review may provide insight for researchers in completing the cytokine network in OLP. Among the etiologic factors, the imbalance between Th-1 and Th-2 cytokine production plays an important role in the development of both diseases. By understanding cytokines and immunoregulatory networks of cytokines in these patients, appropriate treatment can be offered. There are many limitations in cytokine studies, which we have described in this article.

[1]  Alexander C. J. Roth,et al.  Year : 2013 STRING v 9 . 1 : protein-protein interaction networks , with increased coverage and integration , 2017 .

[2]  Yesheng Wei,et al.  The association of interleukin-21 polymorphisms with interleukin-21 serum levels and risk of systemic lupus erythematosus. , 2014, Gene.

[3]  H. Dan,et al.  Interferon-γ and interleukin-4 detected in serum and saliva from patients with oral lichen planus , 2013, International Journal of Oral Science.

[4]  F. Mackay,et al.  Clinical associations of serum interleukin-17 in systemic lupus erythematosus , 2013, Arthritis Research & Therapy.

[5]  Marziyeh Aghazadeh,et al.  Serum Level of Interleukin 17 in Patients with Erosive and Non erosive Oral Lichen Planus , 2013, Journal of dental research, dental clinics, dental prospects.

[6]  J. Hampe,et al.  Disease-Associated miRNA-mRNA Networks in Oral Lichen Planus , 2013, PloS one.

[7]  D. Ye,et al.  Role of interleukin-10 and interleukin-10 receptor in systemic lupus erythematosus , 2013, Clinical Rheumatology.

[8]  S. Galdino,et al.  Decreased serum interleukin 27 in Brazilian systemic lupus erythematosus patients , 2013, Molecular Biology Reports.

[9]  Gang Zhou,et al.  Increasing CCL5/CCR5 on CD4+ T cells in peripheral blood of oral lichen planus. , 2013, Cytokine.

[10]  Zhichun Liu,et al.  Increased interleukin‑9 and CD4+IL-9+ T cells in patients with systemic lupus erythematosus. , 2013, Molecular medicine reports.

[11]  Geneviève Depresseux,et al.  Serum soluble interleukin 7 receptor is strongly associated with lupus nephritis in patients with systemic lupus erythematosus , 2012, Annals of the rheumatic diseases.

[12]  F. Agha-Hosseini,et al.  p53 as a neoplastic biomarker in patients with erosive and plaque like forms of oral lichen planus. , 2013, The journal of contemporary dental practice.

[13]  A. Franek,et al.  Serum levels of selected chemokines in systemic lupus erythematosus patients , 2013, Rheumatology International.

[14]  M. Abdollahi,et al.  Oxidative stress status and DNA damage in saliva of human subjects with oral lichen planus and oral squamous cell carcinoma. , 2012, Journal of oral pathology & medicine : official publication of the International Association of Oral Pathologists and the American Academy of Oral Pathology.

[15]  Jiangquan Zhang,et al.  Serum IL-10 from systemic lupus erythematosus patients suppresses the differentiation and function of monocyte-derived dendritic cells , 2012, Journal of biomedical research.

[16]  Zhigang Xiong,et al.  Implications of Th1 and Th17 cells in pathogenesis of oral lichen planus , 2012, Journal of Huazhong University of Science and Technology. Medical sciences = Hua zhong ke ji da xue xue bao. Yi xue Ying De wen ban = Huazhong keji daxue xuebao. Yixue Yingdewen ban.

[17]  N. Das,et al.  Cytokine imbalance in systemic lupus erythematosus: a study on northern Indian subjects , 2012, Lupus.

[18]  Indra Adrianto,et al.  The genomics of autoimmune disease in the era of genome-wide association studies and beyond. , 2012, Autoimmunity reviews.

[19]  Y. H. Lee,et al.  The association between interleukin-6 polymorphisms and systemic lupus erythematosus: a meta-analysis , 2012, Lupus.

[20]  Salivary and Serum Interleukin-18 in Patients with Oral Lichen Planus: A Study in an Ethnic Chinese Population , 2012, Inflammation.

[21]  S. Appenzeller,et al.  The role of Tumor Necrosis Factor-alpha (TNF-α) in the pathogenesis of systemic lupus erythematosus. , 2011, Cytokine.

[22]  Judy H. Cho,et al.  Genomics and the multifactorial nature of human autoimmune disease. , 2011, The New England journal of medicine.

[23]  T. Rauen,et al.  cAMP-responsive Element Modulator (CREM)α Protein Signaling Mediates Epigenetic Remodeling of the Human Interleukin-2 Gene , 2011, The Journal of Biological Chemistry.

[24]  W. Stohl,et al.  Cytokine disturbances in systemic lupus erythematosus , 2011, Arthritis research & therapy.

[25]  C. Kayser,et al.  IL-2, IL-5, TNF-α and IFN-γ mRNA expression in epidermal keratinocytes of systemic lupus erythematosus skin lesions , 2011, Clinics.

[26]  R. Zhong,et al.  Association of increased serum IL-33 levels with clinical and laboratory characteristics of systemic lupus erythematosus in Chinese population , 2011, Clinical and Experimental Medicine.

[27]  M. Santos,et al.  Interleukin-6 promoter polymorphism −174 G/C is associated with nephritis in Portuguese Caucasian systemic lupus erythematosus patients , 2011, Clinical Rheumatology.

[28]  E. Kassi,et al.  Estrogen Receptor Signaling and Its Relationship to Cytokines in Systemic Lupus Erythematosus , 2010, Journal of biomedicine & biotechnology.

[29]  B. Chiang,et al.  Interleukin 4 and STAT6 gene polymorphisms are associated with systemic lupus erythematosus in Chinese patients , 2010, Lupus.

[30]  M. Gulubova,et al.  Functional genetic polymorphisms in interleukin-12B gene in association with systemic lupus erythematosus , 2010, Rheumatology International.

[31]  Yu Zhou,et al.  Association of Interleukin-8 Gene Polymorphisms and Haplotypes with Oral Lichen Planus in a Chinese Population , 2010, Inflammation.

[32]  M. Abdollahi,et al.  Increased salivary lipid peroxidation in human subjects with oral lichen planus. , 2009, International journal of dental hygiene.

[33]  A. Berghold,et al.  IL10R1 loss-of-function alleles in rheumatoid arthritis and systemic lupus erythematosus. , 2009, Clinical and experimental rheumatology.

[34]  K. Chua,et al.  Interleukin-6 promoter polymorphisms (-174 G/C) in Malaysian patients with systemic lupus erythematosus. , 2009, Brazilian journal of medical and biological research = Revista brasileira de pesquisas medicas e biologicas.

[35]  Weibo Liang,et al.  The IL-16 gene polymorphisms and the risk of the systemic lupus erythematosus. , 2009, Clinica chimica acta; international journal of clinical chemistry.

[36]  D. Ye,et al.  Decreased serum IL-22 levels in patients with systemic lupus erythematosus. , 2009, Clinica chimica acta; international journal of clinical chemistry.

[37]  N. Nishimoto,et al.  Interactions among type I and type II interferon, tumor necrosis factor, and β-estradiol in the regulation of immune response-related gene expressions in systemic lupus erythematosus , 2009, Arthritis research & therapy.

[38]  D. Ye,et al.  Increased serum interleukin 17 in patients with systemic lupus erythematosus , 2009, Molecular Biology Reports.

[39]  T. Fukuda,et al.  Systemic lupus erythematosus associated with facial edema, overproduction of interleukin-5, and eosinophilia. , 2008, Journal of clinical rheumatology : practical reports on rheumatic & musculoskeletal diseases.

[40]  Chien-Feng Li,et al.  Interleukin-20 targets renal mesangial cells and is associated with lupus nephritis. , 2008, Clinical immunology.

[41]  G. Besra,et al.  Congenic Analysis of the NKT Cell Control Gene Nkt2 Implicates the Peroxisomal Protein Pxmp41 , 2008, The Journal of Immunology.

[42]  C. Lam,et al.  Hyperproduction of IL-23 and IL-17 in patients with systemic lupus erythematosus: implications for Th17-mediated inflammation in auto-immunity. , 2008, Clinical immunology.

[43]  Aml S. El-Bendary,et al.  Serum soluble interleukin-2 receptor alpha in systemic lupus erythematosus. , 2008, Iranian journal of kidney diseases.

[44]  S. Hsieh,et al.  Abnormal in vitro CXCR2 modulation and defective cationic ion transporter expression on polymorphonuclear neutrophils responsible for hyporesponsiveness to IL-8 stimulation in patients with active systemic lupus erythematosus. , 2007, Rheumatology.

[45]  A. Markopoulos,et al.  Detection of T cells secreting type 1 and type 2 cytokines in the peripheral blood of patients with oral lichen planus. , 2008, Hippokratia.

[46]  Y. Zhang,et al.  Interleukin-18 gene polymorphisms and haplotypes in patients with oral lichen planus: a study in an ethnic Chinese cohort. , 2007, Tissue antigens.

[47]  A. Guimarães,et al.  Investigation of functional gene polymorphisms interleukin-1beta, interleukin-6, interleukin-10 and tumor necrosis factor in individuals with oral lichen planus. , 2007, Journal of oral pathology & medicine : official publication of the International Association of Oral Pathologists and the American Academy of Oral Pathology.

[48]  É. Hajduch,et al.  IL‐1 receptor antagonist in metabolic diseases: Dr Jekyll or Mr Hyde? , 2006, FEBS letters.

[49]  Ching-Yuang Lin,et al.  Daily urinary interleukin-11 excretion correlated with proteinuria in IgA nephropathy and lupus nephritis , 2006, Pediatric Nephrology.

[50]  Ko-Ron Chen,et al.  A case of lupus erythematosus/lichen planus overlap syndrome , 2006, The Journal of dermatology.

[51]  A. Berghold,et al.  IL 10 R 1 loss-of-function alleles in rheumatoid arthritis and systemic lupus erythematosus , 2006 .

[52]  R. González-Amaro,et al.  IL-15 and IL-15R in leucocytes from patients with systemic lupus erythematosus. , 2005, Rheumatology.

[53]  C. Chiang,et al.  Serum interleukin‐8 level is a more sensitive marker than serum interleukin‐6 level in monitoring the disease activity of oral lichen planus , 2005, The British journal of dermatology.

[54]  D S Latchman,et al.  Raised levels of interleukin 6 in systemic lupus erythematosus correlate with anaemia , 2005, Annals of the rheumatic diseases.

[55]  L. Iaccarino,et al.  Accelerated atherosclerosis in systemic lupus erythematosus , 2004 .

[56]  C. Gordon,et al.  Interleukin (IL)‐10, IL‐1ra and IL‐12 profiles in active and quiescent systemic lupus erythematosus: could longitudinal studies reveal patient subgroups of differing pathology? , 2004, Clinical and experimental immunology.

[57]  Yong-Beom Park,et al.  Elevated interleukin-18 levels correlated with disease activity in systemic lupus erythematosus , 2004, Clinical Rheumatology.

[58]  A. Parodi,et al.  Basiliximab is effective for erosive lichen planus. , 2002, Archives of dermatology.

[59]  I. Todd,et al.  Quantitative and qualitative analysis of the balance between type 1 and type 2 cytokine-producing CD8(-) and CD8(+) T cells in systemic lupus erythematosus. , 2001, Journal of autoimmunity.

[60]  I. Leigh,et al.  Systemic lupus erythematosus presenting with oral mucosal lesions: easily missed? , 2001, The British journal of dermatology.

[61]  M. Carrozzo,et al.  Increased frequency of HLA‐DR6 allele in Italian patients with hepatitis C virus‐associated oral lichen planus , 2001, The British journal of dermatology.

[62]  R. Motley,et al.  Lupus erythematosus/lichen planus overlap syndrome with scarring alopecia , 2001, Journal of the European Academy of Dermatology and Venereology : JEADV.

[63]  C. Wong,et al.  Elevation of proinflammatory cytokine (IL-18, IL-17, IL-12) and Th2 cytokine (IL-4) concentrations in patients with systemic lupus erythematosus , 2000, Lupus.

[64]  L. Klareskog,et al.  Cytokine production, serum levels and disease activity in systemic lupus erythematosus. , 2000, Clinical and experimental rheumatology.

[65]  J. Yiannias,et al.  Relevant contact sensitivities in patients with the diagnosis of oral lichen planus. , 2000, Journal of the American Academy of Dermatology.

[66]  Y. Takasaki,et al.  Levels of IL‐12 in the sera of patients with systemic lupus erythematosus (SLE)—relation to Th1‐ and Th2‐derived cytokines , 1999, Clinical and experimental immunology.

[67]  H. Hashimoto,et al.  Circulating interleukin-16 in systemic lupus erythematosus. , 1998, British journal of rheumatology.

[68]  G. Trinchieri,et al.  Decreased production of interleukin-12 and other Th1-type cytokines in patients with recent-onset systemic lupus erythematosus. , 1998, Arthritis and rheumatism.

[69]  Y. Nagao,et al.  Hepatitis C Virus RNA Detection in Oral Lichen Planus Tissue , 1998, American Journal of Gastroenterology.

[70]  T. Liu,et al.  Impaired production of IL-12 in systemic lupus erythematosus. I. Excessive production of IL-10 suppresses production of IL-12 by monocytes. , 1998, Cytokine.

[71]  M. Mihm,et al.  Involvement of interleukin-3 in delayed-type hypersensitivity. , 1998, Blood.

[72]  J. Ambrus,et al.  A Potential Role for PGE and IL-14 (HMW-BCGF) in B-Cell Hyperactivity of Patients with Systemic Lupus Erythematosus. , 1995, American journal of therapeutics.

[73]  P. Fishman,et al.  Interleukin-3 immunoassay in systemic lupus erythematosus patients: preliminary data. , 1993, International archives of allergy and immunology.

[74]  M. Linker-Israeli,et al.  Elevated levels of endogenous IL-6 in systemic lupus erythematosus. A putative role in pathogenesis. , 1991, Journal of immunology.

[75]  D. Cantrell,et al.  The interleukin-2 T-cell system: a new cell growth model. , 1984, Science.

[76]  K. Göransson,et al.  Oral lichen planus and contact allergy to mercury. , 1982, International journal of oral surgery.

[77]  Zhigang Xiong,et al.  Implications of Th 1 and Th 17 Cells in Pathogenesis of Oral Lichen Planus , 2022 .